Arun Sanyal, MBBS, MD
Disclosures: Advisor-Astra Zeneca|Advisor-Bristol Myers Squibb|Grant or research support-Bristol Myers Squibb|Advisor-Bristol Myers Squibb|Advisor-Gilead|Grant or research support-Gilead|Advisor-Intercept|Advisor-3M (Relationship has ended)|Advisor-AASLD|Advisor-Abbott-St Jude (Relationship has ended)|Advisor-Amag Pharmaceuticals (Relationship has ended)|Advisor-Bausch(Valeant) (Relationship has ended)|Advisor-Blue Bird (Relationship has ended)|Advisor-Boston Scientific (Relationship has ended)|Advisor-Bristol Myers Squibb (Relationship has ended)|Advisor-DePuy Synthese(Johnson&Johnson) (Relationship has ended)|Advisor-Dova (Relationship has ended)|Consulting Fee-Eisai (Relationship has ended)|Advisor-Global Therapeutics (Relationship has ended)|Advisor-Greenwich Biosciences (Relationship has ended)|Advisor-Grifols Shared Services (Relationship has ended)|Advisor-Kaleido Biosciences (Relationship has ended)|Advisor-LivaNova (Relationship has ended)|Advisor-Malinckrodt|Grant or research support-Malinckrodt|Advisor-Mead Johnson Nutrition (Relationship has ended)|Advisor-Medtronic (Relationship has ended)|Advisor-Merz (Relationship has ended)|Advisor-MMS (Relationship has ended)|Advisor-Molnlycke (Relationship has ended)|Advisor-NEVRO (Relationship has ended)|Advisor-Norgine (Relationship has ended)|Consulting Fee-Novartis|Grant or research support-Novartis|Consulting Fee-Pfizer|Advisor-Philips|Advisor-Philips EGI (Relationship has ended)|Advisor-Radius (Relationship has ended)|Advisor-Regerenon Pharmaceuticals|Advisor-St. Jude Medical (Relationship has ended)|Grant or research support-State Grant (Relationship has ended)|Advisor-Summit Medical (Relationship has ended)|Advisor-Supernus Pharma (Relationship has ended)|Advisor-Synlogic (Relationship has ended)|Advisor-Therapeutics MD (Relationship has ended)|Advisor-UCB (Relationship has ended)|Advisor-Valeant (Relationship has ended)|Consulting Fee-Valeant Pharmaceuticals (Relationship has ended)|Consulting Fee-Veritas Collaborative (Relationship has ended) - 11/09/2021

Arun J. Sanyal, M.D

 

Arun J. Sanyal, M.D

Virginia Commonwealth University

1200 East Broad Street P.O. Box 980341

Richmond, Virginia 23298-0341, United States

(804) 828-4060

[email protected]

 

Arun J. Sanyal, M.D., is a Professor of Medicine, Physiology and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. Dr. Sanyal also serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE consortium and the Liver Forum for NASH and fibrosis. His research interests include all aspects of NAFLD and NASH as well as complications of end stage liver disease. He has served as a member of numerous advisory boards to pharmaceutical companies and also the liver center at Yale University.  He chaired the hepatobiliary pathophysiology study section of the NIH and was a founding member of the Hepatology committee of the American Board of Internal Medicine.  He has also served as Secretary as well as President of the American Association for Study of Liver Diseases.  Dr. Sanyal has authored more than 350 articles in such publications as Cell Metabolism, Nature Medicine, New England Journal of Medicine, Lancet, Gastroenterology, Hepatology, and the Journal of Infectious Diseases and has a H-index of 102. He has been continuously funded by the NIH since 1995 and is the principal investigator of four active NIH grants.  He is the recipient of the Distinguished Mentorship Award from the American Gastroenterological Association and the Distinguished Scientific Achievement Award from the American Liver Foundation in 2017 and the Distinguished Achievement Award from the AASLD in 2018